An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for innovative imaging ...

Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...

Sleep data captured with a wearable device could help clinicians better tailor care by identifying patients with chronic obstructive pulmonary disease (COPD) who may need additional support to ...

*Important notice: arXiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or ...

PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DED This FDA-aligned trial ...

Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical outcomes. Thomas Clozel explains how Owkin is training AI on large-scale ...

Kidney diseases develop slowly and may not produce any obvious symptoms for a long time. The body can compensate for them so effectively that the patient remains unaware of the problem for years. It ...

ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+ data in ...

Recent research published in Alzheimer’s & Dementia suggests that older adults with early biological signs of Alzheimer’s ...